The global demand for NGS Sample Preparation Market is presumed to reach the market size of nearly USD 6.23 Billion by 2032 from USD 1.54 Billion in 2023 with a CAGR of 16.76% under the study period 2024-2032.
NGS (Next-Generation Sequencing) sample preparation prepares biological samples for sequencing to analyze genetic material. This preparation involves several key steps: extracting DNA or RNA from cells, fragmenting the nucleic acids, and adding adapters for sequencing. The prepared samples are then amplified to create a library that can be sequenced. Advances in NGS sample preparation have streamlined workflows, increased efficiency, and reduced costs, enabling high-throughput sequencing for applications in genomics, oncology, infectious diseases, and personalized medicine. Accurate sample preparation is crucial for obtaining reliable sequencing data and achieving insights into genetic variations, disease mechanisms, and evolutionary biology.
MARKET DYNAMICS
The growing use of next-generation sequencing (NGS) technologies in research and clinical settings is driven by their capacity to provide comprehensive genomic information quickly and cost-effectively, which is driving the growth of the NGS sample preparation market. Advancements in sample preparation techniques, such as automated platforms and optimized protocols, are improving the efficiency and accuracy of NGS workflows, thereby boosting market demand. Genetic disorders' rising prevalence and focus on personalized medicine propel the need for high-throughput and reliable NGS sample preparation methods. Additionally, increasing investments in genomic research and expanding sequencing capabilities in emerging markets contribute to market growth.
Collaborations between academic institutions, research organizations, and biotechnology companies are fostering innovation and the development of novel NGS sample preparation solutions. Regulatory support for using NGS in clinical diagnostics and the ongoing trend of integrating NGS into routine medical practice further drive market expansion. The continuous development of new applications for NGS, such as in oncology, infectious disease diagnostics, and reproductive health, is also enhancing the demand for efficient sample preparation technologies. However, the high costs of sequencing technologies, the need for highly skilled personnel, and the complexity of data analysis may hinder market growth in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of NGS Sample Preparation Market. The growth and trends of NGS Sample Preparation Market industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the NGS Sample Preparation Market market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
Instruments
Kits, Reagents, and Consumables
By Application
Drug and Biomarker Discovery
Diagnostics
Precision Medicine
Others (agriculture and animal research)
By End-user
Hospitals & Clinical Diagnostic Centers
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
Others (CROs, CMOs etc)
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the NGS Sample Preparation Market market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the NGS Sample Preparation Market market include Qiagen, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Agilent Technologies, Promega Corporation, Illumina Inc., Integrated DNA Technologies Inc., New England Biolabs, Tecan Trading AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
10. COMPANY PROFILES OF NGS SAMPLE PREPARATION MARKET INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Qiagen
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Thermo Fisher Scientific Inc.
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. Merck KGaA
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. F. Hoffmann-La Roche Ltd.
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. Agilent Technologies
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Promega Corporation
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. Illumina Inc.
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. Integrated DNA Technologies Inc.
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
10.11. New England Biolabs
10.11.1 Company Overview
10.11.2 Company Revenue
10.11.3 Products
10.11.4 Recent Developments
10.12. Tecan Trading AG
10.12.1 Company Overview
10.12.2 Company Revenue
10.12.3 Products
10.12.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies